2005 Edition Report on Drug Administration Procedure & Practices ...

More documents

Recommendations

Info

Sensitivity:Prescription/ routewith Doctors’ signature & codeInsulin Administration /Test strip glucoseMonitoring FormHosp # ______________ ID # _____________________Name __________________________________________Sex _____ Age ____ CName ______________________(For Doctors / Nurses Use)Ward____ Bed ____ Dept ______________________H’stix glucose DatePage #monitoring Freq.Date Time Urine H’stix Treatment Given Check Given Remarksketone-ed by byOnOffOnOffOnOffOnOffDate Time Prescription/ route Dr. CheckedbyStat Dose Prescription (Please record under “Remarks”)Givenby.Date Time Prescription/ route Dr. CheckedbyGivenby• PRN insulin should be given before meal • Avoid frequent use of sliding scale which can lead to fluctuating blood glucose control• Capillary blood glucose should be done before or 2-hour post meal or when patient is symptomaticHAHO Apr 021
Intravenous InsulinAdministration Form(DKI or IV insulin pump)Drug allergy ________________Interval of test strip glucose monitoringDate/Time orderedIntervalHospital No: ____________ ID No. _______________Name _________________________________________Sex ______ Age_____ Chinese name_______________Ward______ Bed_____ Department________________Date/TimeDr’s prescriptionInsulin prescriptionDr Sig.TimeBlood glucosemmol/LUrine ketoneIV Insulin PumpInsulin(Units/hr)CheckedbyGivenbyTimestartNurse RecordDextrose Potassium Insulin (DKI) regimenIV fluidInsulin K +OtherTimeadded addedIV fluid Vol (ml)end(units) (mmol) additivesIV fluidinfused(ml)CheckedbyGiven byRemarksInsulin pumpTimeChecked byPrepared byHAHO Apr 022
Page 2 and 3:
ForewordMedication safety and provi
Page 4 and 5:
Chapter 6 summarizes the specific r
Page 6 and 7: Chapter 6Conclusions and Recommenda
Page 8 and 9: CHAPTER ONETHE WORKING GROUPMEMBERS
Page 10 and 11: CHAPTER TWOTHE PROGRESS REPORT2.1 P
Page 12 and 13: CHAPTER THREEAREAS FOR IMPROVEMENT
Page 14 and 15: Existing In-patient Drug Administra
Page 22 and 23: CHAPTER FOURRECOMMENDED PRACTICES A
Page 24 and 25: Drug Name4.11 There should be a hos
Page 26 and 27: Electronic prescribing (Medication
Page 28 and 29: 4.46 When the use of CM is permitte
Page 30 and 31: cytotoxic and central intravenous a
Page 32 and 33: 4.72 Special precautions should be
Page 34 and 35: 4.84 To prevent mixing up medicatio
Page 36 and 37: The Principle of Three checks and F
Page 38 and 39: 4.111 Three-way (red and blue) and
Page 40 and 41: or their discharge or death, should
Page 42 and 43: operational requirement but also it
Page 44 and 45: Quality Complaints on Pharmaceutica
Page 46 and 47: LEVELSHAHOCE / DTOOLS & MECHANISMDU
Page 48 and 49: Medication Incident Report<
Page 50 and 51: Continuing Education6.18 In order t
Page 52 and 53: APPENDICESAppendix 1Appendix 2Appen
Page 54 and 55: Hospital Authority Hospital No. : I
Page 58 and 59: Appendix 3aLists of HA-wide Approve
Page 60 and 61: DRUGTeniposideABBREVIATIONVM-26Thia
Page 62 and 63: Appendix 3b“Do Not Use Abbreviati
Page 64 and 65: Appendix 4Schedule for the Administ
Page 66 and 67: Appendix 5Mechanism for the Managem
Page 68 and 69: 4. As with all medications, there s
Page 70 and 71: Appendix 6HA Guideline on Safe Mana
Page 72 and 73: 2.1 Concentrated potassium chloride
Page 74 and 75: Appendix 7Supply of Antidotes and D
Page 76 and 77: 複本 Antidotes and emeg drug lis
Page 78 and 79: Appendix 8Guidelines for Supply of
Page 80 and 81: substitution with other drugs in ac
Page 82 and 83: Appendix 9Samples of the Line Label
Page 84 and 85: Appendix 10Guidelines on the use of
Page 86 and 87: Appendix 11Guidelines on Patient Se
Page 88 and 89: Operational Guidelines7. The operat
Page 90 and 91: COC(N) Paper 12/2004Approved by COC
Page 92 and 93: 7.4 Evaluation Record and report th
Page 94 and 95: DISPOSAL OF HOSPITAL PHARMACEUTICAL
Page 96 and 97: Appendix 14Guidelines on the Handli
Page 98 and 99: Appendix 15Medication Incident <str
Page 100 and 101: Hospital Authority Medication Incid
Page 102 and 103: QUALITY ASSURANCE IN DRUG THERAPYHO
Page 104 and 105: Fig. 1: ADR voluntary reporting sys
Page 106 and 107:
PROCEUDRE FOR QUALITY COMPLAINTSONP
Page 108:
Part II Procurement Section, CPO1.
show all

2005 Edition Report on Drug Administration Procedure & Practices ...

Create successful ePaper yourself

Delete template?

Save as template?